U.S. federal trademark · Serial No. 90068048 · Reg. No. 2147924
Drug for human use, namely, pharmaceutical preparations for treatment of Covid 19 disease through viral neutralization by means of policlonal equine immunoglobulin fragments Anti-spike glycoprotein of SARS-CoV-2 virus, that is present in such pharmaceutical preparations as the active substance
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.